Kellerhals Carrard, Friedrich Graf von Westphalen & Partner, WST – Studio Associato Servizi Professionali Integrati, bpv BRAUN PARTNERS, Hall & Wilcox, Hall Booth Smith, and Ypsilon...
eps Event Group and NÜSSLI Combine to Form Global Leader in Event Infrastructure
Sale of Majority Stake in Hipp Technology Group to Deutsche Beteiligungs AG
Kellerhals Carrard has advised the shareholders of Hipp Technology Group AG and Endura AG. An investor group represented by Endura AG has sold a majority stake...
Check Point Software Acquires AI Security Startup Lakera
Kellerhals Carrard has advised Lakera and its early investors Atomico and Redalpine. Check Point Software Technologies Ltd., a NASDAQ-listed leader in cybersecurity solutions, has entered into...
HAYA Therapeutics SA’s $65 Million Series A Funding Round
Lenz & Staehelin acted for Eli Lilly; Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital; VISCHER acted for HAYA Therapeutics AG. Wilson Sonsini Goodrich &...
MoonLake Immunotherapeutics’ $500 Million Debt Financing with Hercules Capital
Kellerhals Carrard acted as Swiss counsel to MoonLake Immunotherapeutics on this transaction. DLA Piper and Schellenberg Wittmer acted as legal counsel to Hercules Capital. MoonLake Immunotherapeutics...
Adragos Pharma’s Acquisition of Baccinex
Pestalozzi advised Adragos Pharma on the deal, while Kellerhals Carrard advised the seller. Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in...
Kontivia Beteiligungen AG’s Acquisition Of Minority Stake In Walter Meier AG
Kellerhals Carrard acted as legal advisor to the investors and Kontivia Beteiligungen AG on this transaction. Baker McKenzie advised the sellers on all legal aspects of...
Bruker’s Strategic Partnership with Biognosys
CMS advised Bruker, while Kellerhals Carrard advised Biognosys AG. Biognosys AG and Bruker Corporation (Nasdaq: BRKR) announced a strategic partnership, in which Bruker has made a...
NLS Pharmaceutics’ $30 Million Purchase Agreement with BVF Partners L.P.
Kellerhals Carrard advised BVF on the deal while Sheppard Mullin served as counsel to Laidlaw & Company (UK) Ltd. NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss...
Kontivia AG-Led Entrepreneurs Group’s Acquisition of Katadyn Group
Advestra advised the sellers. Kellerhals Carrard advised the investors and Kontivia AG on this transaction. Adrian Schmassmann, CEO and long-time majority shareholder of Katadyn Group, together...
MoonLake Immunotherapeutics AG’s Business Combination With Helix Acquisition Corp.
Kellerhals Carrard, working alongside Walkers, instructed by onshore law firm Gibson, Dunn & Crutcher LLP, advised MoonLake Immunotherapeutics AG on this transaction. Pestalozzi advised Helix Acquisition...
MoonLake Immunotherapeutics AG’s Series A Financing Round
Kellerhals Carrard acted as lead legal advisor to MoonLake Immunotherapeutics AG on this transaction. Walder Wyss has advised Merck KGaA on the deal. MoonLake Immunotherapeutics AG,...